{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:08:20Z","timestamp":1793729300187,"version":"4.6.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The objective of this study was to identify clinicopathologic parameters associated with disease outcome in FIGO stage I vulvar squamous cell carcinoma (vSqCC). The cohort consisted of 126 patients diagnosed with vSqCC in the period 2006\u20132016 who underwent primary vulvar surgery and evaluation of groin lymph node status. Tumors were reviewed by an experienced gynecologic pathologist. p16 and p53 protein expression by immunohistochemistry and HPV status were analyzed in 116 tumors. Clinicopathologic parameters, protein expression and HPV status were analyzed for association with progression-free and overall survival (PFS, OS). p16 expression and aberrant p53 were found in 49 (42%) and 61 (53%) tumors, respectively. Sixty-six tumors were HPV-associated (57%). Relapse was diagnosed in 35\/126 (28%) of patients, and 23 (18%) died of disease. Tumor diameter\u2009&gt;\u20094\u00a0cm (<jats:italic>p<\/jats:italic>\u2009=\u20090.013), lymphovascular space invasion (LVSI; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), the presence of lichen sclerosus (<jats:italic>p<\/jats:italic>\u2009=\u20090.019), p16 expression (<jats:italic>p<\/jats:italic>\u2009=\u20090.007), p53 expression (<jats:italic>p<\/jats:italic>\u2009=\u20090.012), HPV status (<jats:italic>p<\/jats:italic>\u2009=\u20090.021), lymph node metastasis (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and post-operative radiotherapy (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) were significantly related to OS in univariate analysis. Tumor diameter\u2009&gt;\u20094\u00a0cm (<jats:italic>p<\/jats:italic>\u2009=\u20090.038), LVSI (<jats:italic>p<\/jats:italic>\u2009=\u20090.003), the presence of lichen sclerosus (<jats:italic>p<\/jats:italic>\u2009=\u20090.004), p16 expression (<jats:italic>p<\/jats:italic>\u2009=\u20090.004), HPV status (<jats:italic>p<\/jats:italic>\u2009=\u20090.039), lymph node metastasis (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and post-operative treatment (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), were significantly related to PFS in univariate analysis. Age, BMI and surgical resection involvement were not significantly associated with OS or PFS. In multivariate Cox analysis, LVSI and p16 expression were independent prognosticators of OS (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 and <jats:italic>p<\/jats:italic>\u2009=\u20090.02, respectively) and PFS (<jats:italic>p<\/jats:italic>\u2009=\u20090.018, <jats:italic>p<\/jats:italic>\u2009=\u20090.037). In conclusion, LVSI and p16 expression are independent prognostic factors in stage I vSqCC.<\/jats:p>","DOI":"10.1007\/s00428-023-03670-y","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:02:16Z","timestamp":1697439736000},"page":"951-963","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lymphovascular invasion and p16 expression are independent prognostic factors in stage I vulvar squamous cell carcinoma"],"prefix":"10.1007","volume":"484","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3332-8427","authenticated-orcid":false,"given":"Ben","family":"Davidson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tone","family":"Skeie-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arild","family":"Holth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Lindemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Toralba Barrameda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes Kathrine","family":"Lie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"key":"3670_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"3670_CR2","unstructured":"WHO Classification of Tumours Editorial Board (2020) Female Genital Tumours, vol 4, 5th edn. IARC, Lyon"},{"key":"3670_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1053\/j.semdp.2020.09.004","volume":"38","author":"CJ Julia","year":"2021","unstructured":"Julia CJ, Hoang LN (2021) A review of prognostic factors in squamous cell carcinoma of the vulva: evidence from the last decade. Semin Diagn Pathol 38:37\u201349. https:\/\/doi.org\/10.1053\/j.semdp.2020.09.004","journal-title":"Semin Diagn Pathol"},{"issue":"Suppl 1","key":"3670_CR4","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1097\/PGP.0000000000000900","volume":"41","author":"L Hoang","year":"2022","unstructured":"Hoang L, Webster F, Bosse T, Focchi G, Gilks CB, Howitt BE, McAlpine JN, Ordi J, Singh N, Wong RW, Lax SF, McCluggage WG (2022) Data set for the reporting of carcinomas of the vulva: recommendations from the International Collaboration on Cancer Reporting (ICCR). Int J Gynecol Pathol 41(Suppl 1):S8\u2013S22. https:\/\/doi.org\/10.1097\/PGP.0000000000000900","journal-title":"Int J Gynecol Pathol"},{"key":"3670_CR5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ygyno.2021.12.020","volume":"164","author":"JL Schleiss-Andreassen","year":"2022","unstructured":"Schleiss-Andreassen JL, Kristensen E, Fr\u00f8ding LP, St\u00e6hr E, H\u00f8gdall C, Christiansen AP, H\u00f8gdall E, Schnack TH (2022) Assessment of recurrence rate and risk factors of relapse in stage in IA vulvar carcinoma. Gynecol Oncol 164:543\u2013549. https:\/\/doi.org\/10.1016\/j.ygyno.2021.12.020","journal-title":"Gynecol Oncol"},{"key":"3670_CR6","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/s41379-020-0524-1","volume":"33","author":"B Tessier-Cloutier","year":"2020","unstructured":"Tessier-Cloutier B, Kortekaas KE, Thompson E, Pors J, Chen J, Ho J, Prentice LM, McConechy MK, Chow C, Proctor L, McAlpine JN, Huntsman DG, Gilks CB, Bosse T, Hoang LN (2020) Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status. Mod Pathol 33:1595\u20131605. https:\/\/doi.org\/10.1038\/s41379-020-0524-1","journal-title":"Mod Pathol"},{"key":"3670_CR7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/path.4424","volume":"234","author":"M Arbyn","year":"2014","unstructured":"Arbyn M, Tommasino M, Depuydt C, Dillner J (2014) Are 20 human papillomavirus types causing cervical cancer? J Pathol 234:431\u2013435. https:\/\/doi.org\/10.1002\/path.4424","journal-title":"J Pathol"},{"key":"3670_CR8","unstructured":"IARC (2022) Cervical cancer screening. IARC Handb Cancer Prev 18:1\u2013456. Available from: https:\/\/publications.iarc.fr\/604"},{"key":"3670_CR9","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.ygyno.2003.11.052","volume":"92","author":"AP Pinto","year":"2004","unstructured":"Pinto AP, Schlecht NF, Pintos J, Kaiano J, Franco EL, Crum CP, Villa LL (2004) Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma. Gynecol Oncol 92:856\u2013865. https:\/\/doi.org\/10.1016\/j.ygyno.2003.11.052","journal-title":"Gynecol Oncol"},{"key":"3670_CR10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ygyno.2009.12.031","volume":"117","author":"G Lindell","year":"2010","unstructured":"Lindell G, N\u00e4sman A, Jonsson C, Ehrsson RJ, Jacobsson H, Danielsson KG, Dalianis T, K\u00e4llstr\u00f6m BN, Larson B (2010) Presence of human papillomavirus (HPV) in vulvar squamous cell carcinoma (VSCC) and sentinel node. Gynecol Oncol 117:312\u2013316. https:\/\/doi.org\/10.1016\/j.ygyno.2009.12.031","journal-title":"Gynecol Oncol"},{"key":"3670_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ygyno.2011.05.016","volume":"122","author":"I Alonso","year":"2011","unstructured":"Alonso I, Fust\u00e9 V, del Pino M, Castillo P, Torn\u00e9 A, Fust\u00e9 P, Rios J, Pahisa J, Balasch J, Ordi J (2011) Does human papillomavirus infection imply a different prognosis in vulvar squamous cell carcinoma? Gynecol Oncol 122:509\u2013514. https:\/\/doi.org\/10.1016\/j.ygyno.2011.05.016","journal-title":"Gynecol Oncol"},{"key":"3670_CR12","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/PAS.0000000000000454","volume":"39","author":"F Dong","year":"2015","unstructured":"Dong F, Kojiro S, Borger DR, Growdon WB, Oliva E (2015) Squamous cell carcinoma of the vulva: a subclassification of 97 cases by clinicopathologic, immunohistochemical, and molecular features (p16, p53, and EGFR). Am J Surg Pathol 39:1045\u20131053. https:\/\/doi.org\/10.1097\/PAS.0000000000000454","journal-title":"Am J Surg Pathol"},{"key":"3670_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ygyno.2016.05.019","volume":"142","author":"LJ Lee","year":"2016","unstructured":"Lee LJ, Howitt B, Catalano P, Tanaka C, Murphy R, Cimbak N, DeMaria R, Bu P, Crum C, Horowitz N, Matulonis U, Viswanathan AN (2016) Prognostic importance of human papillomavirus (HPV) and p16 positivity in squamous cell carcinoma of the vulva treated with radiotherapy. Gynecol Oncol 142:293\u2013298. https:\/\/doi.org\/10.1016\/j.ygyno.2016.05.019","journal-title":"Gynecol Oncol"},{"key":"3670_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/his.13205","volume":"71","author":"JN McAlpine","year":"2017","unstructured":"McAlpine JN, Leung SCY, Cheng A, Miller D, Talhouk A, Gilks CB, Karnezis AN (2017) Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study. Histopathology 71:238\u2013246. https:\/\/doi.org\/10.1111\/his.13205","journal-title":"Histopathology"},{"key":"3670_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/ijgc-2019-000793","volume":"30","author":"L Proctor","year":"2020","unstructured":"Proctor L, Hoang L, Moore J, Thompson E, Leung S, Natesan D, Chino J, Gilks B, McAlpine JN (2020) Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinoma. Int J Gynecol Cancer 30:100\u2013106. https:\/\/doi.org\/10.1136\/ijgc-2019-000793","journal-title":"Int J Gynecol Cancer"},{"key":"3670_CR16","doi-asserted-by":"publisher","first-page":"3739075","DOI":"10.1155\/2020\/3739075","volume":"2020","author":"EL Barlow","year":"2020","unstructured":"Barlow EL, Lambie N, Donoghoe MW, Naing Z, Hacker NF (2020) The clinical relevance of p16 and p53 status in patients with squamous cell carcinoma of the vulva. J Oncol 2020:3739075. https:\/\/doi.org\/10.1155\/2020\/3739075","journal-title":"J Oncol"},{"key":"3670_CR17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ygyno.2020.09.024","volume":"159","author":"KE Kortekaas","year":"2020","unstructured":"Kortekaas KE, Bastiaannet E, van Doorn HC, de Vos van Steenwijk PJ, Ewing-Graham PC, Creutzberg CL, Akdeniz K, Nooij LS, van der Burg SH, Bosse T, van Poelgeest MIE (2020) Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes. Gynecol Oncol 159:649\u2013656. https:\/\/doi.org\/10.1016\/j.ygyno.2020.09.024","journal-title":"Gynecol Oncol"},{"key":"3670_CR18","doi-asserted-by":"publisher","unstructured":"Eva L, Sadler L, Thompson JM, Sahota S, Fong KL, Jones RW, Bigby SM (2022) HPV-independent and HPV-associated vulvar squamous cell carcinoma: two different cancers. Int J Gynecol Cancer ijgc-2022\u2013003616. https:\/\/doi.org\/10.1136\/ijgc-2022-003616","DOI":"10.1136\/ijgc-2022-003616"},{"key":"3670_CR19","doi-asserted-by":"publisher","unstructured":"Gadducci A, Simonetti E, Cosio S, Fanucchi A, Dolci V, Laliscia C, Naccarato AG, Pistolesi S (2023) Positive p16 immunostaining is an independent prognostic variable for disease-free survival and overall survival in patients with squamous cell carcinoma of the vulva treated with radical surgery and inguinofemoral lymphadenectomy: an Italian Single Center Retrospective Study. Anticancer Res 43:1643\u20131648. https:\/\/doi.org\/10.21873\/anticanres.16315","DOI":"10.21873\/anticanres.16315"},{"key":"3670_CR20","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1002\/ijc.31006","volume":"141","author":"N Rakislova","year":"2017","unstructured":"Rakislova N, Clavero O, Alemany L, Saco A, Quir\u00f3s B, Lloveras B, Alejo M, Pawlita M, Quint W, Del Pino M, de Sanjose S, Ordi J, VVAP study group (2017) Histological characteristics of HPV-associated and -independent squamous cell carcinomas of the vulva: a study of 1,594 cases. Int J Cancer 141:2517\u20132527. https:\/\/doi.org\/10.1002\/ijc.31006","journal-title":"Int J Cancer"},{"key":"3670_CR21","doi-asserted-by":"publisher","first-page":"086","DOI":"10.1093\/jnci\/djv086","volume":"107","author":"M Saraiya","year":"2015","unstructured":"Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, Copeland G, Cozen W, Peters ES, Huang Y, Saber MS, Altekruse S, Goodman MT, HPV Typing of Cancers Workgroup (2015) US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst 107:086. https:\/\/doi.org\/10.1093\/jnci\/djv086","journal-title":"J Natl Cancer Inst"},{"key":"3670_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ygyno.2022.06.014","volume":"166","author":"CL Rasmussen","year":"2022","unstructured":"Rasmussen CL, Thomsen LT, Baandrup L, Franzmann MB, Larsen LG, Madsen EM, Salinas NV, Schledermann D, Winberg BH, \u00d8rnskov D, Waldstr\u00f8m M, Kjaer SK (2022) Changes in HPV prevalence in Danish women with vulvar cancer during 28 years - A nationwide study of >1300 cancer cases. Gynecol Oncol 166:589\u2013595. https:\/\/doi.org\/10.1016\/j.ygyno.2022.06.014","journal-title":"Gynecol Oncol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-023-03670-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-023-03670-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-023-03670-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T22:02:51Z","timestamp":1718834571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-023-03670-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["3670"],"URL":"https:\/\/doi.org\/10.1007\/s00428-023-03670-y","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,16]]},"assertion":[{"value":"31 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained according to national and institutional guidelines. Study approval was given by the Regional Committee for Medical Research Ethics in Norway.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"None declared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}